ArticleMolecular cancer therapeutics2025

Broadening the Therapeutic Window of ADCs Using Site-Specific Bioconjugation Showcased by an MMAE-Containing Peptide Linker in a CD79b-Targeting ADC.

Philipp Probst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.